Materias dentro de su búsqueda.
Mostrando 101 - 120 Resultados de 200 Para Buscar '"SEGA"', tiempo de consulta: 0.12s Limitar resultados
  1. 101
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Transcriptomic profiling of calcified aortic valves in clonal hematopoiesis of indeterminate potential carriers
  2. 102
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A serum proteome signature to predict mortality in severe COVID-19 patients
  3. 103
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effects of long-term fluoride exposure are associated with oxidative biochemistry impairment and global proteomic modulation, but not genotoxicity, in parotid glands of mice
  4. 104
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease
  5. 105
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    How Does Fingolimod (Gilenya(®)) Fit in the Treatment Algorithm for Highly Active Relapsing-Remitting Multiple Sclerosis?
  6. 106
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    HorTILLUS—A Rich and Renewable Source of Induced Mutations for Forward/Reverse Genetics and Pre-breeding Programs in Barley (Hordeum vulgare L.)
  7. 107
    por Giani, Alessandro, Cipriani, Federica, Famularo, Simone, Donadon, Matteo, Bernasconi, Davide Paolo, Ardito, Francesco, Fazio, Federico, Nicolini, Daniele, Perri, Pasquale, Giuffrida, Mario, Pontarolo, Nicholas, Zanello, Matteo, Lai, Quirino, Conci, Simone, Molfino, Sarah, Germani, Paola, Pinotti, Enrico, Romano, Maurizio, La Barba, Giuliano, Ferrari, Cecilia, Patauner, Stefan, Manzoni, Alberto, Sciannamea, Ivano, Fumagalli, Luca, Troci, Albert, Ferraro, Valentina, Floridi, Antonio, Romano, Fabrizio, Ciulli, Cristina, Braga, Marco, Ratti, Francesca, Costa, Guido, Razionale, Francesco, Russolillo, Nadia, Marinelli, Laura, De Peppo, Valerio, Cremaschi, Elena, Calabrese, Francesco, Larghi Laureiro, Zoe, Lazzari, Giovanni, Cosola, Davide, Montuori, Mauro, Salvador, Luca, Cucchetti, Alessandro, Franceschi, Angelo, Ciola, Michele, Sega, Valentina, Calcagno, Pietro, Pennacchi, Luca, Tedeschi, Michele, Memeo, Riccardo, Crespi, Michele, Chiarelli, Marco, Antonucci, Adelmo, Zimmitti, Giuseppe, Frena, Antonio, Percivale, Andrea, Ercolani, Giorgio, Zanus, Giacomo, Zago, Mauro, Tarchi, Paola, Baiocchi, Gian Luca, Ruzzenente, Andrea, Rossi, Massimo, Jovine, Elio, Maestri, Marcello, Dalla Valle, Raffaele, Grazi, Gian Luca, Vivarelli, Marco, Ferrero, Alessandro, Giuliante, Felice, Torzilli, Guido, Aldrighetti, Luca, Gianotti, Luca
    Publicado 2020
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Performance of Comprehensive Complication Index and Clavien-Dindo Complication Scoring System in Liver Surgery for Hepatocellular Carcinoma
  8. 108
    “…PURPOSE: Subependymal giant cell astrocytoma (SEGA) is a brain tumor associated with tuberous sclerosis complex (TSC). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex
  9. 109
    “…There is minimal information on SEGA evolution in adults with TSC. Of 2,211 patients enrolled in TOSCA, 220 of the 803 adults (27.4%) ever had a SEGA. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Newly Diagnosed and Growing Subependymal Giant Cell Astrocytoma in Adults With Tuberous Sclerosis Complex: Results From the International TOSCA Study
  10. 110
    “…The neurologic manifestation is characterized by cortical tubers, subependymal nodules (SEN), and subependymal giant cell astrocytoma (SEGA) in brain. SEGAs may result in hydrocephalus in TSC patients and mTORC1 inhibitors are the current recommended therapy for SEGA. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Characterization of a Subependymal Giant Astrocytoma-Like Cell Line from Murine Astrocyte with mTORC1 Hyperactivation
  11. 111
    “…Subependymal giant cell astrocytoma (SEGA) is an indolent neoplasm which usually arises at the cauda thalamic groove near foramen monro, although it occurs usually in the clinical settings of TSC, a few number of SEGA has been reported without such history. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    CD99: A potential Diagnostic Marker for Differentiating Sub-ependymal Giant Cell Astrocytoma From Other Mimickers: A Report of Five Cases
  12. 112
    “…BACKGROUND: Subependymal giant cell astrocytoma (SEGA) is occasionally seen in tuberous sclerosis complex (TSC). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility
  13. 113
    “…Direct surgical resection remains to be the standard treatment for tuberous sclerosis complex (TSC) with subependymal giant cell astrocytoma (SEGA). Medical therapy with everolimus (mammalian target of rapamycin inhibitor or mTOR) serves as a second-line treatment for patients with SEGA who are determined to be ineligible for surgical resection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Neoadjuvant Therapy with Everolimus for Subependymal Giant Cell Astrocytoma: A Case Report
  14. 114
    “…Conclusions: Although SEGA diagnosis and growth typically occurs during childhood, SEGA can occur and grow in both infants and adults.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical Characteristics of Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex
  15. 115
    “…This includes the growth of low-grade brain tumors, known as subependymal giant cell astrocytomas (SEGA). Previous studies have shown differential expression of genes related to the extracellular matrix in SEGA. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Dysregulation of the MMP/TIMP Proteolytic System in Subependymal Giant Cell Astrocytomas in Patients With Tuberous Sclerosis Complex: Modulation of MMP by MicroRNA-320d In Vitro
  16. 116
    “…BACKGROUND: Subependymal giant cell astrocytoma (SEGA) is a benign intraventricular tumor classically arising near the Foramen of Monro. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Subependymal giant cell astrocytoma in the absence of tuberous sclerosis: illustrative case
  17. 117
    “…Previous reported described histopathological predictors of more aggressive forms, terms atypical SEGA in infantile age group. Other reports showed possible transformation of SEGA into glioblastoma, or misdiagnosis as glioblastoma due to the presence of atypical histopathological features. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Infantile atypical subependymal giant cell astrocytoma
  18. 118
    “…Subependymal giant cell astrocytoma (SEGA) is the most common intracranial tumor in tuberous sclerosis (TS) patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Subependymal Giant Cell Astrocytoma Apoplexy: A Case Report and Systematic Review
  19. 119
    “…Here, we present a case of SEGA with squash cytologic findings and a review of cytology findings of SEGA presently available in the literature. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Intraoperative Squash Cytologic Features of Subependymal Giant Cell Astrocytoma
  20. 120
    “…Everolimus was initiated at a dose (4.5 mg/m(2)/day) titrated to a target blood trough of 5–15 ng/mL. SEGA response rate (primary end point) was defined as the proportion of patients achieving confirmed ≥50% reduction in the sum volume of target SEGA lesions from baseline in the absence of worsening nontarget SEGA lesions, new target SEGA lesions, and new or worsening hydrocephalus. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study
Herramientas de búsqueda: RSS